Oncology Medical News about adjuvant neck dissection

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Annals of Oncology, 10/20/09

Sher DJ et al. – Patients with node–positive head and neck squamous cell carcinomas (HNC) have a significant risk of residual disease (RD) in the neck after treatment, despite optimal chemoradiotherapy (CRT). Adjuvant neck dissection (ND) after CRT has been considered standard treatment, but its morbidity has led investigators to consider using post–CRT imaging to determine the need for surgery. Adjuvant ND reserved for patients with RD on PET–CT is the dominant and cost–effective strategy.

<< Previous
Care for the Bodies of Deceased Cancer Inpatients in Japanese...

Next >>
Safety, tolerability, pharmacokinetics and pharmacodynamics of...

Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Thyroid, 11/02/09 Relevance Score: 70%

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09 Relevance Score: 69%

Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09 Relevance Score: 69%

Management of the N0 neck in recurrent laryngeal squamous cell carcinoma
The Laryngoscope, 11/02/09 Relevance Score: 68%

Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09 Relevance Score: 68%